INIS
patients
100%
fibers
60%
pain
41%
diseases
20%
sodium
16%
nerves
16%
mutations
15%
symptoms
13%
netherlands
13%
data
13%
comparative evaluations
12%
genes
12%
inflammation
12%
genetics
11%
quality of life
11%
assessments
10%
control
9%
evaluation
9%
testing
8%
gain
8%
therapy
8%
clinical trials
8%
immunoglobulins
7%
muscles
7%
voltage
7%
screening
7%
reviews
7%
density
6%
losses
6%
chemotherapy
6%
Keyphrases
Small Fiber Neuropathy
51%
Myotonic Dystrophy
24%
Painful Diabetic Neuropathy
15%
Neuropathic Pain
14%
Nav1.7
14%
Netherlands
10%
Neuropathy
10%
Diabetic Neuropathy
9%
Guillain-Barré Syndrome
9%
Rasch
9%
Quality of Life
7%
Disability Scale
6%
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
6%
SCN9A
6%
Randomized Controlled Trial
6%
Sodium Channel
6%
Chemotherapy-induced Peripheral Neuropathy
6%
Duchenne muscular Dystrophy
5%
Diabetic Peripheral Neuropathy
5%
Voltage-gated Sodium Channel
5%
Clinical Trials
5%
Lacosamide
5%
Medicine and Dentistry
Small Fiber Neuropathy
38%
Neuropathy
18%
Myotonic Dystrophy
16%
Diabetic Neuropathy
16%
Diseases
12%
Neuropathic Pain
10%
Quality of Life
8%
Nerve Fiber
7%
Sodium Channel
7%
Placebo
6%
Randomized Controlled Trial
5%
Immunoglobulin
5%
Polyradiculoneuropathy
5%
